Search Results - "Yoshida, Ryohei"

Mechano- and Thermo-responsive Luminescence of Crystalline Thienylbenzothiadiazole Derivatives: Stepwise Hypsochromic Switching of Near-Infrared Emission by Yoshida, Ryohei, Tachikawa, Takashi, Ito, Suguru

“…Organic crystals that exhibit mechanochromic luminescence (MCL) switch their emission colors in response to mechanical stimuli, and the original emission…”
Get full text

Effect of alloy element on weld pool dynamics in laser welding of aluminum alloys by Miyagi, Masanori, Wang, Hongze, Yoshida, Ryohei, Kawahito, Yousuke, Kawakami, Hiroshi, Shoubu, Takahisa

“…In this manuscript, weld pool dynamics in laser welding of various series of aluminum alloys were investigated by the in situ X-ray phase contrast imaging…”
Get full text

Real-World Efficacy of Ensitrelvir in Hospitalized Patients With COVID-19 in Japan: A Retrospective Observational Study by Yoshida, Ryohei, Sasaki, Takaaki, Ohsaki, Yoshinobu

“…The coronavirus disease 2019 (COVID-19) pandemic necessitates continuously evaluating antiviral treatments, especially for high-risk groups, including older…”
Get full text

Neuromyelitis optica spectrum disorder secondary to treatment with anti-PD-1 antibody nivolumab: the first report by Narumi, Yoshitsugu, Yoshida, Ryohei, Minami, Yoshinori, Yamamoto, Yasushi, Takeguchi, Shiori, Kano, Kohei, Takahashi, Kae, Saito, Tsukasa, Sawada, Jun, Terui, Hiroya, Katayama, Takayuki, Sasaki, Takaaki, Ohsaki, Yoshinobu

“…Immune checkpoint blockade is developed as standard treatment for non-small cell lung cancer. However immune-related adverse events (irAE) have still unknown…”
Get full text

MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer by Yoshida, Ryohei, Saigi, Maria, Tani, Tetsuo, Springer, Benjamin F, Shibata, Hirofumi, Kitajima, Shunsuke, Mahadevan, Navin R, Campisi, Marco, Kim, William, Kobayashi, Yoshihisa, Thai, Tran C, Haratani, Koji, Yamamoto, Yurie, Sundararaman, Shriram K, Knelson, Erik H, Vajdi, Amir, Canadas, Israel, Uppaluri, Ravindra, Paweletz, Cloud P, Miret, Juan J, Lizotte, Patrick H, Gokhale, Prafulla C, Jänne, Pasi A, Barbie, David A

“…Immunotherapy has shown limited efficacy in patients with EGFR-mutated lung cancer. Efforts to enhance the immunogenicity of EGFR-mutated lung cancer have been…”
Get full text

Monitoring epidermal growth factor receptor C797S mutation in Japanese non–small cell lung cancer patients with serial cell‐free DNA evaluation using digital droplet PCR by Ariyasu, Ryo, Uchibori, Ken, Sasaki, Takaaki, Tsukahara, Mika, Kiyotani, Kazuma, Yoshida, Ryohei, Ono, Yusuke, Kitazono, Satoru, Ninomiya, Hironori, Ishikawa, Yuichi, Mizukami, Yusuke, Yanagitani, Noriko, Fujita, Naoya, Nishio, Makoto, Katayama, Ryohei

“…Osimertinib is a third‐generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) that is effective in treating both naïve and…”
Get full text

Highly sensitive detection of ALK resistance mutations in plasma using droplet digital PCR by Yoshida, Ryohei, Sasaki, Takaaki, Umekage, Yasuhiro, Tanno, Sachie, Ono, Yusuke, Ogata, Munehiko, Chiba, Shinichi, Mizukami, Yusuke, Ohsaki, Yoshinobu

“…On-target resistance mechanisms found in one-third of patients receiving anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) are secondary ALK…”
Get full text

Tumor-Derived cGAMP Regulates Activation of the Vasculature by Campisi, Marco, Sundararaman, Shriram K, Shelton, Sarah E, Knelson, Erik H, Mahadevan, Navin R, Yoshida, Ryohei, Tani, Tetsuo, Ivanova, Elena, Cañadas, Israel, Osaki, Tatsuya, Lee, Sharon Wei Ling, Thai, Tran, Han, Saemi, Piel, Brandon P, Gilhooley, Sean, Paweletz, Cloud P, Chiono, Valeria, Kamm, Roger D, Kitajima, Shunsuke, Barbie, David A

“…Intratumoral recruitment of immune cells following innate immune activation is critical for anti-tumor immunity and involves cytosolic dsDNA sensing by the…”
Get full text

Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer by Yoshida, Ryohei, Sasaki, Takaaki, Minami, Yoshinori, Hibino, Yukiko, Okumura, Shunsuke, Sado, Masatoshi, Miyokawa, Naoyuki, Hayashi, Satoshi, Kitada, Masahiro, Ohsaki, Yoshinobu

“…Anaplastic lymphoma kinase (ALK) fusion oncogenes occur in approximately 3-5% of non-small cell lung cancer (NSCLC) cases. Various ALK inhibitors are in…”
Get full text

Case Report: Case series: association between blood concentration and side effects of sotorasib by Shigaki, Ryota, Yoshida, Ryohei, Yagita, Akari, Nagasue, Kazunori, Naraoka, Taeka, Nitanai, Kiichi, Yanada, Hiraku, Tenma, Toshiyuki, Kida, Ryotaro, Umekage, Yasuhiro, Mori, Chie, Minami, Yoshinori, Sato, Hideki, Iwayama, Kuninori, Hashino, Yasuhisa, Fukudo, Masahide, Sasaki, Takaaki

“…Introduction Sotorasib is a crucial therapeutic agent for patients with non-small cell lung cancer (NSCLC) harboring the KRAS p.G12C mutation. Despite its…”
Get full text

Two Cases of SMARCA4-Deficient Non-small Cell Lung Cancer (NSCLC) with Improved Performance Status (PS) after Treatment with Immune Checkpoint Inhibitors (ICIs) by Koizumi, Akiko, Tamura, Yukiho, Yoshida, Ryohei, Mori, Chie, Ono, Yusuke, Tanino, Mishie, Mizukami, Yusuke, Sasaki, Takaaki

“…SWItch/Sucrose Non-Fermentable (SWI/SNF)-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4 (SMARCA4) mutations are…”
Get full text

The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancer by Okazaki, Satoshi, Sasaki, Takaaki, Yasuda, Shunsuke, Abe, Masahiro, Yoshida, Nana, Yoshida, Ryohei, Ishibashi, Kei, Minami, Yoshinori, Okumura, Shunsuke, Chiba, Shinichi, Takei, Hidehiro, Hayashi, Ryusuke, Nagato, Toshihiro, Kobayashi, Hiroya, Sugitani, Ayumu, Ono, Yusuke, Mizukami, Yusuke, Kitada, Masahiro, Ohsaki, Yoshinobu

“…Triple-negative breast cancer (TNBC) has a poorer prognosis than other breast cancer subtypes; therefore, identifying markers of early recurrence is important…”
Get full text

A Non-stoichiometric Universality in Microbubble-Polyelectrolyte Complexation by Frusawa, Hiroshi, Yoshida, Ryohei

Get full text

Sterilization of Fusarium oxysporum by treatment of non-thermalequilibrium plasma in nutrient solution by Yasui, Shinji, Seki, Satoshi, Yoshida, Ryohei, Shoji, Kazuhiro, Terazoe, Hitoshi

“…Fusarium wilt of spinach due to F. oxysporum infection is one of the most destructive root diseases in hydroponics in factories using the nutrient film…”
Get full text

Characteristics of Learning Motivation of Vocational College Entrants from School and not Directly from School: A 3-year Comparative Study of Occupational and Physical Therapy Department Students by YOSHIZUKA, Hisayoshi, SHIMOJO, Seiko, HONDA, Yuichi, YOSHIDA, Ryohei, ASAMI, Toyoko

“…[Purpose] To clarify the differences and commonalities in the learning motivation of students in physical and occupational therapy vocational colleges, between…”
Get full text

Mechanoresponsive luminescence switching by polymorphs and doped crystals of donor–acceptor-type benzothiadiazoles by Ito, Suguru, Nagai, Sayaka, Yoshida, Ryohei, Ubukata, Takashi, Tachikawa, Takashi

“…Abstract only…”
Get full text

Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer by Kitajima, Shunsuke, Ivanova, Elena, Guo, Sujuan, Yoshida, Ryohei, Campisi, Marco, Sundararaman, Shriram K, Tange, Shoichiro, Mitsuishi, Yoichiro, Thai, Tran C, Masuda, Sayuri, Piel, Brandon P, Sholl, Lynette M, Kirschmeier, Paul T, Paweletz, Cloud P, Watanabe, Hideo, Yajima, Mamiko, Barbie, David A

“…-driven lung cancers frequently inactivate and/or , defining tumor subclasses with emerging clinical relevance. Specifically, - (KL)-mutant lung cancers are…”
Get more information

EGFR and KRAS Mutations in Triple-Mutated Lung Cancer by Yoshida, Ryohei, Sasaki, Takaaki, Ohsaki, Yoshinobu

Get more information

MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancer by Kitajima, Shunsuke, Tani, Tetsuo, Springer, Benjamin F., Campisi, Marco, Osaki, Tatsuya, Haratani, Koji, Chen, Minyue, Knelson, Erik H., Mahadevan, Navin R., Ritter, Jessica, Yoshida, Ryohei, Köhler, Jens, Ogino, Atsuko, Nozawa, Ryu-Suke, Sundararaman, Shriram K., Thai, Tran C., Homme, Mizuki, Piel, Brandon, Kivlehan, Sophie, Obua, Bonje N., Purcell, Connor, Yajima, Mamiko, Barbie, Thanh U., Lizotte, Patrick H., Jänne, Pasi A., Paweletz, Cloud P., Gokhale, Prafulla C., Barbie, David A.

“…KRAS-LKB1 (KL) mutant lung cancers silence STING owing to intrinsic mitochondrial dysfunction, resulting in T cell exclusion and resistance to programmed cell…”
Get full text

Abstract 3148: Activation of Src signaling mediates acquired resistance to ALK inhibition in lung cancer by Yoshida, Ryohei, Sasaki, Takaaki, Okumura, Shunsuke, Ohsaki, Yoshinobu

“…Abstract Anaplastic lymphoma kinase (ALK) fusion oncogenes occur in around 3%-5% non-small cell lung cancer (NSCLC) cases. Various ALK inhibitors are in…”
Get full text